Institute of Medical Immunology at the Charité - Universitätsmedizin Berlin
Hans-Dieter Volk has been director of the BCRT since its establishment in 2006. In addition, he is head of the Institute of Medical Immunology at the Charité - Universitätsmedizin Berlin since 1994, and the Department of Immunology of the Labor Berlin-Charité Vivantes GmbH since 2011. Taking a translational approach, Hans-Dieter Volk combines basic and clinical research in immunology. This has allowed him and his team to develop new diagnostic products and therapies for immune diseases, which are already on the market. His research work focuses on the development of biomarkers, transplantation immunology, the immunopathogenesis of virus infections of the herpes group of viruses, and the role of inhibitory cytokines and regulatory T cells. Hans-Dieter Volk works closely with other research groups at Charité and the BCRT as well as a number of biotech and pharma companies and the Charité Research Organization GmbH to translate his research findings into clinical applications as quickly as possible. The institute has spawned a number of successful biotech spin-off companies including Jerini AG, ProBioGen AG, T Cell Europe GmbH and Cellserve GmbH.